78 related articles for article (PubMed ID: 11710941)
1. Protein tyrosine phosphatase genes downregulated in melanoma.
McArdle L; Rafferty M; Maelandsmo GM; Bergin O; Farr CJ; Dervan PA; O'Loughlin S; Herlyn M; Easty DJ
J Invest Dermatol; 2001 Nov; 117(5):1255-60. PubMed ID: 11710941
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of phosphatase gene expression in human melanoma.
McArdle L; Rafferty MM; Satyamoorthy K; Maelandsmo GM; Dervan PA; Herlyn M; Easty DJ
Br J Dermatol; 2005 May; 152(5):925-30. PubMed ID: 15888148
[TBL] [Abstract][Full Text] [Related]
3. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
Easty DJ; Ganz SE; Farr CJ; Lai C; Herlyn M; Bennett DC
J Invest Dermatol; 1993 Nov; 101(5):679-84. PubMed ID: 8228328
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of PTP pi, a novel receptor-like protein-tyrosine phosphatase.
Crossland S; Smith PD; Crompton MR
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):249-54. PubMed ID: 8870675
[TBL] [Abstract][Full Text] [Related]
5. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
Florio T; Scorziello A; Thellung S; Salzano S; Berlingieri MT; Fusco A; Schettini G
Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinases in malignant melanoma.
Easty DJ; Bennett DC
Melanoma Res; 2000 Oct; 10(5):401-11. PubMed ID: 11095400
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S
BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135
[TBL] [Abstract][Full Text] [Related]
8. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression and mutational analysis of SH-PTP2, human protein-tyrosine phosphatase.
Bastien L; Ramachandran C; Liu S; Adam M
Biochem Biophys Res Commun; 1993 Oct; 196(1):124-33. PubMed ID: 8216283
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
Eberle J; Weitmann S; Thieck O; Pech H; Paul M; Orfanos CE
J Invest Dermatol; 1999 Jun; 112(6):925-32. PubMed ID: 10383740
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatase expression in pre-B cell NALM-6.
Adachi M; Sekiya M; Arimura Y; Takekawa M; Itoh F; Hinoda Y; Imai K; Yachi A
Cancer Res; 1992 Feb; 52(3):737-40. PubMed ID: 1370651
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.
Easty DJ; Mitchell PJ; Patel K; Flørenes VA; Spritz RA; Bennett DC
Int J Cancer; 1997 Jun; 71(6):1061-5. PubMed ID: 9185712
[TBL] [Abstract][Full Text] [Related]
15. Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 -/- mice.
Sorenson CM; Sheibani N
Am J Physiol Renal Physiol; 2002 Mar; 282(3):F442-50. PubMed ID: 11832424
[TBL] [Abstract][Full Text] [Related]
16. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
Krasagakis K; Fimmel S; Genten D; Eberle J; Quas P; Ziegler W; Haller H; Orfanos CE
Int J Oncol; 2002 Apr; 20(4):865-71. PubMed ID: 11894137
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphate in melanoma progression.
McArdle L; Bergin O; Fallowfield ME; Dervan PA; Easty DJ
Br J Dermatol; 2003 Aug; 149(2):289-95. PubMed ID: 12932234
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
20. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
Givant-Horwitz V; Davidson B; Reich R
Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
